These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 6217586

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F, Koopman J, Kluft C, D'Angelo A, Cattaneo M, Mannucci PM.
    Thromb Haemost; 1986 Feb 28; 55(1):131-5. PubMed ID: 3705000
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The release of small amounts of fibrinopeptide-B (FPB) is of critical importance for the thrombin clotting time.
    Holm B, Kierulf P, Godal HC.
    Thromb Res; 1986 May 15; 42(4):517-26. PubMed ID: 3715815
    [Abstract] [Full Text] [Related]

  • 27. Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA.
    Engesser L, Koopman J, de Munk G, Haverkate F, Nováková I, Verheijen JH, Briët E, Brommer EJ.
    Thromb Haemost; 1988 Aug 30; 60(1):113-20. PubMed ID: 3142089
    [Abstract] [Full Text] [Related]

  • 28. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M, Yamanaka A, Morimoto Y, Akihama S.
    Biol Pharm Bull; 1993 May 30; 16(5):448-52. PubMed ID: 8364489
    [Abstract] [Full Text] [Related]

  • 29. Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II.
    Borrell M, Vila L, Solá J, Coll I, Gómez N, González N, Rutllant ML.
    Thromb Res; 1987 Mar 01; 45(5):591-9. PubMed ID: 3109061
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
    Okumura N, Terasawa F, Haneishi A, Fujihara N, Hirota-Kawadobora M, Yamauchi K, Ota H, Lord ST.
    J Thromb Haemost; 2007 Dec 01; 5(12):2352-9. PubMed ID: 17922804
    [Abstract] [Full Text] [Related]

  • 33. Dysfibrinogenaemia associated with a defect in the aggregation of the fibrin monomers (Almeria I fibrinogen). A preliminary study.
    Vila V, Regañon E, Fernandez-Pavon A, Aznar J.
    Scand J Haematol; 1984 Nov 01; 33(5):460-5. PubMed ID: 6515329
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Congenital dysfibrinogenemia: fibrinogen Lille.
    Denninger MH, Finlayson JS, Reamer LA, Parquet-Gernez A, Goudemand M, Menache D.
    Thromb Res; 1978 Sep 01; 13(3):453-66. PubMed ID: 741439
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
    Bolliger-Stucki B, Lord ST, Furlan M.
    Blood; 2001 Jul 15; 98(2):351-7. PubMed ID: 11435303
    [Abstract] [Full Text] [Related]

  • 39. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD.
    Prog Clin Pathol; 1984 Jul 15; 9():15-45. PubMed ID: 6229812
    [No Abstract] [Full Text] [Related]

  • 40. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J, Luo M, Cheng P, Liao L, Deng X, Deng D, Lin F.
    Int J Hematol; 2017 Apr 15; 105(4):506-514. PubMed ID: 27933517
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.